Skip to main content Skip to navigation


Select tags to filter on

New Publication for Warwick Evidence

Armoiry, X., Spath, H.-M., Clarke, A., Connock, M., Sutcliffe, P. & Dussart, C. (2019) Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma. Journal of Market Access & Health Policy, 7 (1): 1648971.

For the full paper see here.

New publication for Warwick Evidence

Armoiry, X., Connock, M., Tsertsvadze, A., Cummins, E., Melendez-Torres, G. J., Royle, P. & Clarke, A. (2018) Ixazomib for Relapsed or Refractory Multiple Myeloma: Review from an Evidence Review Group on a NICE Single Technology Appraisal. Pharmacoeconomics.

Click here to see the full article

New publication for Warwick Evidence

Verran, A., Uddin, A., Court, R., Taggart, F., Sutcliffe, P., Sturt, J., Griffiths, F. & Atherton, H. (2018) Effectiveness and impact of networked communication interventions in young people with mental health conditions: A rapid review. DIGITAL HEALTH, 4 2055207618762209.

Warwick Evidence New Publications

Griffiths FE, Armoiry X, Atherton H, Bryce C, Buckle A, Cave JAK, et al. The role of digital communication in patient-clinician communication for NHS providers of specialist clinical services for young people [the Long-term conditions Young people Networked Communication (LYNC) study]: a mixed-methods study. Health Serv Deliv Res 2018;6(9).

To view the full article click here.

Maheswaran, Hendramoorthy, Petrou, Stavros, Cohen, D., MacPherson, Peter, Kumwenda, F., Laloo, D. G., Corbett, Elizabeth L. and Clarke, Aileen (2018) Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence : a prospective hospital cohort study in Blantyre, Malawi. PLoS One . (In Press)

Older news